Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

844
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
844
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

188
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
188
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

30
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
30

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Higher incidence of hepatocellular carcinoma in suppressed hepatitis B cirrhosis compared to cured hepatitis C cirrhosis.

The American journal of gastroenterology·2026
Same author

Editorial: Do we Need to Adapt GERD Metrics Based on the Population Being Evaluated? Authors' Reply.

Alimentary pharmacology & therapeutics·2026
Same author

Letter: From Regional Diagnostic Thresholds to Phenotype-Guided Management in Asian Reflux Disease. Authors' Reply.

Alimentary pharmacology & therapeutics·2026
Same author

Editorial: Liver and Non-Liver Outcomes Between Different Subtypes of Steatotic Liver Disease.

Alimentary pharmacology & therapeutics·2026
Same author

Ambient nitrogen oxides exposure associated with hepatic steatosis in patients with chronic hepatitis B.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same author

Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease: Presentation, Health Care Burden, and Risk Stratification.

Neurogastroenterology and motility·2026
Same journal

Heterogeneity Analyzed by CT-Based Habitat Analysis for Clinical Management of Cancers: A Narrative Review.

The Kaohsiung journal of medical sciences·2026
Same journal

TRIM Expression and Its Association With Disease Activity in Systemic Lupus Erythematosus.

The Kaohsiung journal of medical sciences·2026
Same journal

Rare Cutaneous Metastasis From Esophageal Squamous Cell Carcinoma.

The Kaohsiung journal of medical sciences·2026
Same journal

Rhaponticin Blocks Glycolysis-Mediated Histone Lactylation to Suppress Tongue Squamous Cell Carcinoma via HIF-1α Activity Inhibition.

The Kaohsiung journal of medical sciences·2026
Same journal

A Retrospective Study on Neonatal Jaundice: Early Risk Stratification Value of DAT-FAT Serological Profiles Confirmed by AET.

The Kaohsiung journal of medical sciences·2026
Same journal

Association Between Triglyceride-Glucose Index and in-Hospital Intensive Care Unit Readmission in Ischemic Stroke Patients: A Retrospective Analysis Based on the MIMIC-IV Database.

The Kaohsiung journal of medical sciences·2026
See all related articles

Related Experiment Video

Updated: Aug 31, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.1K

Modifications decrease hepatic steatosis in Taiwanese with metabolic-associated fatty liver disease.

Tso-Tsai Liu1, He Qiu2, Shi-Yu Liu3

  • 1Department of Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan.

The Kaohsiung Journal of Medical Sciences
|August 22, 2022
PubMed
Summary
This summary is machine-generated.

Lifestyle modifications significantly reduced liver fat in obese patients with metabolic-associated fatty liver disease (MAFLD). Transient elastography (TE) effectively monitored these improvements in hepatic steatosis over three months.

Keywords:
fatty liverlifestyle interventionnonalcoholic fatty liver diseasenonalcoholic steatohepatitisweight loss

More Related Videos

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.0K
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

6.6K

Related Experiment Videos

Last Updated: Aug 31, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.1K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.0K
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

6.6K

Area of Science:

  • Hepatology
  • Metabolic Diseases
  • Obesity Research

Background:

  • Metabolic-associated fatty liver disease (MAFLD) is a growing global health concern, closely linked to rising obesity rates.
  • Current recommendations for MAFLD management emphasize lifestyle modifications, including diet, exercise, and weight reduction.

Purpose of the Study:

  • To assess the short-term impact of a structured lifestyle modification program on liver fat and fibrosis in obese patients with MAFLD.
  • To evaluate the utility of transient elastography (TE) parameters, including controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), in monitoring treatment response.

Main Methods:

  • A prospective study involving 32 obese patients diagnosed with MAFLD who underwent a 3-month lifestyle modification program.
  • Demographic data, biochemical tests, and TE measurements (CAP and LSM) were recorded before and after the intervention period.
  • Statistical analysis compared pre- and post-intervention parameters to determine the effects of lifestyle changes.

Main Results:

  • Significant improvements were observed in body weight, body mass index, waist and hip circumference, and blood pressure post-intervention.
  • Key biochemical markers, including AST, ALT, creatinine, cholesterol, GGT, and LDL cholesterol, showed significant reductions.
  • The average CAP, indicating liver fat content, significantly decreased, while liver stiffness measurements (LSM) showed no significant change.

Conclusions:

  • Short-term lifestyle modifications are effective in improving hepatic steatosis in obese patients with MAFLD.
  • Transient elastography, particularly the CAP measurement, can serve as a valuable tool for monitoring the effectiveness of therapeutic interventions for liver fat reduction.